Skip to main content

Defendants’ Talc Suit Summary Judgment Motion Denied

Defendants’ Talc Suit Summary Judgment Motion Denied

Defendants’ Talc Suit Summary Judgment Motion Denied

Introduction

In an order submitted on December 10, the New York Supreme Court rejected Colgate-Palmolive's motion for summary judgment in a Cashmere Bouquet talcum powder lawsuit with the conclusion that the issue still remained whether the plaintiff's use of the talcum powder led to her mesothelioma. The order stated summary judgment could not be granted “when there is any doubt” on causation.

The plaintiff claimed in her lawsuit that she developed mesothelioma as she was in contact with Colgate-Palmolive Co.’s cosmetic talc product from 1968 through 1985. She filed suit against Imerys Talc America, Inc. and Cyprus Amax Minerals Companies blaming them for her illness. In their motion for summary judgment, the defendants, Imerys and Cyprus asserted that they both are Delaware corporations and were not involved in mining, manufacturing, research, development, designing, or testing of the talcum powder in the state hence, they cannot be held liable in New York for the damages caused to the plaintiff. The Supreme Court denied their motion considering that both companies actively sold and shipped talc to Colgate-Palmolive in New York for nearly six years hence the case must proceed to trial.

Mesothelioma affected plaintiffs have filed asbestos exposure lawsuits in several state and county courts. Individuals working in factories and mines where asbestos products are used often fall prey to the deadly form of cancer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!